TGR-1202,
umbralisib,
Umbralisib,
rp-5264,
1532533-67-7,
TGR-1202,
TGR1202,
TGR-1202 base,
UNII-38073MQB2A,
(S)-2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one,
38073MQB2A,
AK173784,
Umbralisib [USAN],
TGR-1202 free base,
umbralisib (TGR-1202),
GTPL8916,
CHEMBL3948730,
SCHEMBL15557416,
KS-00001CWZ,
IUVCFHHAEHNCFT-INIZCTEOSA-N,
TGR 1202 [WHO-DD],
BDBM184556,
2-[(1S)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one,
BCP24686,
EX-A1645,
TGR 1202,
MFCD28386165,
RP5264,
s8194,
example A1 [US2014011819],
ZINC141831516,
CS-5243,
RP 5264,
SB16920,
AS-52257,
HY-12279,
US9150579, B1,
2-((1S)-1-(4-Amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one,
A16277,